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Abstract
Background: Molecular classification of tumors can be achieved by global gene expression profiling. Most
machine learning classification algorithms furnish global error rates for the entire population. A few algorithms
provide an estimate of probability of malignancy for each queried patient but the degree of accuracy of these
estimates is unknown. On the other hand local minimax learning provides such probability estimates with best
finite sample bounds on expected mean squared error on an individual basis for each queried patient. This allows
a significant percentage of the patients to be identified as confidently predictable, a condition that ensures that the
machine learning algorithm possesses an error rate below the tolerable level when applied to the confidently
predictable patients.
Results: We devise a new learning method that implements: (i) feature selection using the k-TSP algorithm and
(ii) classifier construction by local minimax kernel learning. We test our method on three publicly available gene
expression datasets and achieve significantly lower error rate for a substantial identifiable subset of patients. Our
final classifiers are simple to interpret and they can make prediction on an individual basis with an individualized
confidence level.
Conclusions: Patients that were predicted confidently by the classifiers as cancer can receive immediate and
appropriate treatment whilst patients that were predicted confidently as healthy will be spared from unnecessary
treatment. We believe that our method can be a useful tool to translate the gene expression signatures into
clinical practice for personalized medicine.
Background
As developing gene expression signature from microar-
ray data becomes a routine strategy to predict clinical
outcome or to classify molecular tumor subtypes, com-
putational methods that are capable of extracting accu-
rate and simple decision rules from such microarray
data are of great interest in personalized medicine [1-5].
Various gene expression signatures and classifiers have
been identified recently; however, only a handful of
these signatures are translated from bench research to
clinical trials. Several factors contribute to this problem
from the bioinformatics perspective: First, the lack of
interpretability in the resulting classification rules (gene
expression signatures), generated from standard machine
learning approaches, leaves a mystery for clinicians. Sec-
ond, the number of genes involved in the classifiers
ranges from tens to hundreds; interpreting, validating,
implementing and translating these classification rules
to the clinician represent a daunting task. Third, in
order to achieve personalized prediction due to a
patient’s tumor heterogeneity, the classification rules
have to be able to provide a predicted probability of
malignancy with a level of confidence where both quanti-
ties vary with the individual patient.T h i sp r e d i c t i o n
capability is not available in current machine learning
approaches [6,7]. Finally, other technical and biological
issues were described in [8] that hindered the translation
of gene signatures in clinical practice.
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devise a novel statistical framework for personalized pre-
diction with accurate and simple decision rules from
microarray gene expression data [9]; where for each
patient we are able to give an individualized analysis. For
each patient we generate a predictor vector whose
k components consist of the differences of signal intensi-
ties from tissue samples from k gene pairs. For two class
pattern recognition problems (with patient labels 0 for
normal and 1 for cancer), we use local minimax learning
to obtain both an estimate of the probability that a
patient with a given predictor vector belongs to class
1 (cancer) and a confidence interval for the true probabil-
ity. The length of the confidence interval varies (as does
the probability estimate) with the given query so that the
action taken for a given query may depend on both
degree of confidence (inverse of length of confidence
interval) and degree of predictability (nearness of prob-
ability estimate to 0 or 1). Indeed, in practice, classifica-
tion algorithms are often only one step in a larger
sequential decision procedure. Final decisions may only
be reached if the classification process yields high degrees
of both confidence and predictability. We define confi-
dent predictability for a patient in terms of the above two
degrees and examine the machine learning algorithm
performance for the confidently predictable patients.
Otherwise, for non-confidently predictable patients,
further measurements and testing may be desired.
A local minimax learning algorithm may be applied
directly to (i) raw predictor data or to (ii) predictor data
of reduced dimensionality after feature selection via vir-
tually any favorite machine learning algorithm. However,
although it is believed that local minimax learning will
compete favorably with many machine learning algo-
rithms, for case (i) difficult optimization problems need
to be solved (hopefully they will be solved as a result of
future computational research) to implement the techni-
ques of optimal fusion and optimal local kernel shape
determination derived in [10]. Also it is almost always
the case that understanding the science behind the sta-
tistical problem leads naturally to appropriate feature
selection. Hence we report here on implementations of
type (ii) only.
Our framework consists of two major steps: 1) feature
selection and 2) prediction and error estimation. We
used the k-Top Scoring Pairs algorithm (k-TSP) [9] for
feature selection yielding a k dimensional feature space
with coordinates given by the gene pair intensity differ-
ences described previously. The prediction and error
estimation are based on the theory of Local Minimax
learning [10]. We applied the local minimax prediction
algorithms based on the Improved Tikhonov Estimator
for kernel machine learning to estimate a given patient’s
probability of having cancer. The idea of local learning
is to individualize the prediction process: the determina-
tion of the probability of cancer for a patient is
“tailored” to the neighborhood of the patient’s predictor
vector. For comparison a nearest neighbor algorithm
with a (only asymptotically valid) confidence interval
was similarly applied.
Methods
Feature selection method
We used k-Top Scoring Pairs (k-TSP)[ 9 ]a l g o r i t h ma s
feature selection method in this study. Suppose we have
N patients with known diagnoses (0 for normal or 1 for
cancer) and for each patient we are given a vector g of
real numbers consisting of the values of signal intensi-
ties of tissue samples from G genes. For any pair of
genes (i, j) we can determine the relative frequency that
gi <g j among the normal patients and also compute this
relative frequency for the cancer patients. We determine
ag e n ep a i r( i, j) for which the absolute difference of the
two relative frequencies is greatest. Using this absolute
difference, we can order all the gene pairs from the
greatest to the lowest. In case of ties, we replace the sig-
nal intensities of each gene by their ranks among the
N patients and compute the average within class rank
difference for gene pairs and break the tie by maximiz-
ing the absolute class difference (See [9] for more effi-
cient algorithms.). In this study, we fixed k =1 0t o
select the top 10 disjoint gene pairs as the learning fea-
tures for the local minimax algorithm.
We note that in the feature selection the true classes
of the patients are used. This will affect the local mini-
max probability estimate as discussed below but the
width of the confidence interval will remain valid.
Prediction and error estimation
S u p p o s ew eh a v eN patients with known diagnoses and
for each patient we are given a vector of k real numbers
consisting of the values of k selected features. The i-th
number represents the difference of signal intensities for
the i-th top scoring pair. Typically N is in the range of a
few dozen to a few hundred and we set k =1 0i nt h i s
study. We represent the j-th patient vector by xj.L e tYj
be 1 for those who have cancer and 0 for those who do
not. A new patient is now considered and we are given
his feature values in the vector x0. Let f (x) Prob {cancer
| feature vector x}. We will assume that f (x)i sac o n -
stant plus a finite sum of kernel functions centered at
arbitrary points in a given sphere V about x0 in k
dimensional space. (Actually this representation only
needs to equal the above probabilities at xj for j = 0,1,...,
N ) We represent the kernel function as K (z, x)where z
is the center and x varies over the sphere V. We used
the kernel
Kz x e
xz xz
t
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fraction of the distance of the query x0 to the
furthest xj. We took that fraction as 0.5 and 0.7 in the
experiments reported here. Other fixed fractions could
also be used. Or one could use a fixed fraction of the
mean distance from the query to a patient in the train-
ing set, or a fixed fraction of the distance to the j-th clo-
sest patient, etc. Cross validation for determining is not
recommended as it will give a global average for which
would detract from accurate local analysis.
Since taking any linear combination of kernels above
will be equivalent to assuming the set of such f ’s is dense
in the set of all continuous functions, we restricted the
linear combinations to be possibly probability functions
(meaning 0 <f (x) < 1) and to have a degree of smooth-
ness directly proportional to s. In particular f(x) = a +(1-
a)f1(x) - af2(x) (for a fixed, 0 <a < 1) where each fl (l =
1,2) is a positive finite sum of kernels centered at arbi-
trary points {zi} ⊂V where each 0 <fl (x) < 1 in V. (Denote
the class of such f ’sb yPKa (V ). We took a =0 . 5i no u r
experiments although we present the results for any a).
Actually we only need to assume that there is an f in PKa
(Vi) that takes the same values as the true probabilities at
the data points and query in the sphere Vi below and
where {zi} ⊂Vi.W eo b t a i na ne s t i m a t eo ff (x0)o ft h e
form Fw w w Y jj
j
N
() =+
= ∑ *
1
, together with a bound on mean
squared error (MSE) and a one sided 90% confidence
interval. These three quantities are furnished by the
improved Tikhonov estimator (1),(2) and (3) below:
( w h i c hi sd e r i v e di nf u l li n[ 1 0 ]( a n do u t l i n e di nt h e
appendix) by the method of local minimax learning).
First assume the patient training vectors are ordered
by their distance to the query x0. Vi is the ball centered
at x0 of radius equal to the distance from x0 to the i -th
closest training vector where iÎ{1,2,...,N} is optimally
chosen to minimize the bound (1). (i.e. an optimal
neighborhood is chosen to which the contextual Tikho-
nov estimator of [10] is applied).
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where the i + 1 dimensional diagonal matrix s*=diag
{0,0.25,0.25,...,0.25}, Kij m Kxx
* , = () , j,m=0,1,2,...,i .
(In [10] it is proposed to further optimize by varying the
kernel function appropriately over those with trace of
the kernel covariance equal k/s
2).
In fact our estimator is identical to that furnished by
first least squares fitting the data in the above Vi to a
function g(x) with a penalty term (0.5/MVi )
2 [g,g]
2,
where [,]is the reproducing kernel inner product (see
appendix), and then using g(xo) as the estimate. This
penalized least squares procedure is the well known
Tikhonov regularization. For a proof of the identity of
our estimator and a Tikhonov regularization see Theo-
rem VI in [10].
A complete outline of Reproducing Kernel Hilbert
space (RKHS) and the derivation from 3 stated local
minimax results (to which the reader may give his/her
own proofs) is given in the appendix. References are
given to the full proofs of these three results in [10].
Now the preceding results are valid provided the fea-
ture selection process does not depend on the patient
classes Yj but only on the patient raw predictor vectors g.
However if we could find N new patients with exactly the
same Nx j’s as the training set then the results using the
Yi ’s for these new patients would be valid for the queried
patient. Of course we can not find such patients easily
but the MSE bounds (and hence the width of confidence
intervals) depend only on the xj . Hence with top scoring
pairs as a feature selection method only the probability
estimators F (w) depend on the new Yj.W ec a na p p r o x i -
mate such F (w) by adjusting the estimator by an
(expected) resampling shift and then using the invariant
MSE bound to form the approximate confidence interval:
First suppose the true overall total error rate with the
given feature space is 0. Then the new patients (even
t h o u g hw ec a nn o tf i n dt h e mi n practice) will have the
same Yj and the results are valid for the original training
set. For a true overall total error rate of e we can generate
an approximate new “adjusted” F (w) by replacing the
original Yj in the formula for F (w) by the value e if Yj =0
or 1-e if Yj = 1. Now the true overall total error rate is
l i k e l yt ob eq u i t es m a l la sm achine learning suffers from
the curse of dimensionality. So we report results here
with adjustments (e) of e = 0.00 and e = 0.05.
Results
Microarray gene expression datasets
To demonstrate the utility of the local minimax algo-
rithm, we tested it on three publicly available microarray
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described in [11] for separating ALL from AML using
microarray gene expression profiles. In total, there are
47 ALL and 25 AML samples and 7,129 gene features.
Prostate Cancer. This data set is described in [12]. The
gene expression profiles contain 38 tumors and 50 nor-
mal prostate samples and 12,625 gene features. Global
cancer map (GCM). This gene expression data set repre-
sents a collection of 280 various tumors (190) and nor-
mal (90) samples. The classification task is to
distinguish tumors from normal based on 16,063 gene
features [13].
Leave-one-out cross-validation
For all the experiments, we employed leave-one-out
cross-validation to assess the classification performance.
In brief, for each data set of size N, we left out one sam-
ple, and performed feature extraction and classifier con-
structed based on the N-1 member training set. The
classifier constructed from the N-1 member training set
is used to predict the left out sample. This procedure is
repeated N times.
Predictability threshold and accuracy
When applying one of our classification algorithms to a
given patient’s predictor vector (gene expression profile),
we not only obtain an estimate F of the probability that
a patient has cancer (whence we classify the patient into
class 0 for normal if F is less than 0.5, or else we classify
the patient as class 1 for cancer), but we also obtain a
90% one-sided confidence interval for that patient’s pre-
dicted probability. Since we are estimating a probability
-∞ and +∞ may be replaced in the confidence interval
expressions (3) by 0 and 1 respectively.
One use of such an algorithm is to divide patients into
a group of those for whom we may confidently predict
and those for whom lack of sufficient confidence or pre-
dictability may warrant further (possibly invasive) test-
ing. This dichotomy is achieved using what we call a
predictability threshold p as follows: we fix a probability
value, call it p; for example p = 0.35. We then designate
as confidently predictable at level p, all patients whose
confidence interval associated with their prediction lies
entirely inside of the interval [0, p] or lies entirely inside
the interval [1-p, 1]. All other patients are considered to
be non-confidently predictable. It follows that if a
patient is confidently predictable (CP) with threshold p
then either [0, p] or [1-p, 1] contains the true probabil-
ity with 90% or more confidence.
Table 1 summarizes our results using 10-Top Scoring
Pairs for feature selection on the three microarray gene
expression data sets. Predictions for each patient were
made based on their raw predictor vector using the raw
predictor and response data for the remaining patients
("leave-one-out” method). That is, the feature space was
determined using the raw data for the remaining patients.
Sigma (s) denotes the bandwidth of the Gaussian ker-
nel in units of distance in predictor feature space from
the queried patient’s predictor to the furthest predictor
among the rest of the patients. We report two sigma
values (0.5 and 0.7) using the threshold p = 0.35 on
these data sets in Table 1. In Table 1, we reported the
results of e = 0.00 and 0.05 as adjustments to F (w).
From Table 1, we observed that, with 10 pair differences
as features, more than 50% of the AML/ALL patients may
be identified as confidently predictable and that their error
is reduced from 4% to 0%. Similarly 55% of the GCM
patients may be separated and their error is reduced from
14% to less than 4%. For the prostate data set about one-
third of the patients get their error rate cut by 70%.
Varying sigma (s)
In Figure 1 we plot %CP and %error in CP as a function
of sigma from 0.2 to 1.4. In general confidence widths
may be narrower for larger sigma but the true probabil-
ity function must be assumed to be very smooth.
Confident predictability with 3-nearest neighbor predictor
We only demonstrate improved classification for the
kernel classifier using squared error loss. Finite sample
Table 1 Kernel method, sigma = 0.5 and 0.7, threshold,
p = 0.35, adjustment, e = 0.00 and 0.05
Data set Sigma Adjustment
(e)
CP (%) Error in CP
(%)
Total Error
(%)
Leukemia 0.5 0 36
(50.0%)
0 (0%) 3 (4.17%)
0.05 25
(34.7%)
0 (0%) 3 (4.17%)
0.7 0 43
(59.7%)
0 (0%) 3 (4.17%)
0.05 36
(50.0%)
0 (0%) 3 (4.17%)
Prostate 0.5 0 32
(36.4%)
4 (12.5%) 21 (23.9%)
0.05 30
(34.1%)
3 (10.0%) 21 (23.9%)
0.7 0 34
(38.6%)
4 (11.8%) 22 (25.0%)
0.05 25
(28.4%)
2 (8.00%) 22 (25.0%)
GCM 0.5 0 154
(55.0%)
6 (3.90%) 39 (13.9%)
0.05 134
(47.9%)
3 (2.24%) 39 (13.9%)
0.7 0 160
(57.1%)
6 (3.75%) 42 (15.0%)
0.05 134
(47.9%)
5 (3.73%) 42 (15.0%)
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machine learning algorithms. However, for nearest
neighbor algorithms, we may use asymptotic properties
to define confident predictability and compare with our
finite sample methods. The 3-nearest neighbor algo-
rithm represents a simple local learning method whose
predictions represent a baseline predictive power of
asymptotic local learning approaches. The gain of our
proposed methods can be assessed by comparing to the
3-nearest neighbor predictor. For this purpose, we
implemented a 3-nearest neighbor predictor in this
study. Employing the same leave-one-out cross valida-
tion procedure as previously described, we compared
the 3-nearest neighbor predictor against the kernel pre-
dictors with sigma 0.5 and 0.7 on the three microarray
data sets. Assuming the true probability of cancer for
any patient is either at most 0.30 or at least 0.70, confi-
dent predictability for p = 0.35 (as sample size
approaches infinity) can be defined as “all 3-nearest
neighbors belong to the same class”.T a b l e2s h o w st h e
results of the comparisons of CP (%), error in CP (%)
and total error(%).
As indicated in Table 2, the local minimax kernel
methods had a greatly reduced % error in CP while the
3-nearest neighbor predictor had little or no reduction
in two cases and, in the remaining case, had a CP (%)
error nearly double that for the kernel method. This is
expected since the 3-nearest neighbor confidence
depends on virtually infinite sample size while local
minimax learning bounds are optimal for finite samples.
Application to individual patients
One of the novel contributions of the current method is
its ability to provide both predictive power and confi-
dence level for individual patients. We selected four
patients from the GCM data set to illustrate these
unique features of personalized prediction. For the
patients in the GCM data set, the kernel method for
10-TSP with sigma = 0.5 was used. In this data set, we
applied confident predictability (CP) with the assump-
tion p = 0.35. We took the adjustment parameter e = 0.
Patient 12
Based on the gene expression profile of this patient’s tis-
sues, they are correctly predicted to be cancerous with
an estimated probability of 0.962. The square root of
the mean square error bound (RMSE) is 0.081 (90% CI,
0.831 to 1.0). This patient is in the confidently predict-
able group. Given a prediction with this accuracy, a phy-
sician can initiate the treatment for this patient without
further invasive diagnostic tests which might cause the
disease to spread more rapidly. Giving the right treat-
ment at the right time may stabilize the tumor cells.
Patient 209
From the gene expression profile, the kernel algorithm
(correctly) predicted this normal patient’st i s s u ea sc a n -
cerous with an estimated probability of 0. The RMSE
was 0.209 and the confidence interval was [0, 0.226].
This is considered a confident prediction. In the clinical
setting, this patient can be assured by the physician that
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Figure 1 The relationships between sigma, percentage of confidence predictable (CP) patients and the percentage of error in CP
patients in the three microarray data sets.
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future.
Patient 244
The predicted probability for cancer was 0.579 with
RMSE of 0.072. The 90% CI was [0.462, 1.0]. Although
the RMSE was quite small the true probability of cancer
was too close to 0.5 to make a firm decision. The
patient may be advised by the physician to undertake
further different noninvasive diagnostic tests. This non-
confidently predictable patient did not have cancer but
would have been classified as cancer if the decision were
based on the probability estimate alone.
Patient 253
The predicted probability for cancer was 0.837 with
RMSE of 0.159. Although the probability estimate was
quite high the RMSE was more than double that of
patient 244 and the confidence interval was [0.579, 1.0].
This patient may be advised by the physician to under-
take further different noninvasive diagnostic tests. This
non-confidently predictable patient did not have cancer
but would have been certainly been diagnosed as having
cancer if the decision were based on the probability esti-
mate alone.
We also plotted the probability estimate and upper
and lower confidence curves as a function of sigma for
the four patients in Figure 2. In general the user may
want to set a lower limit on sigma - say the fraction
given by the distance to the (N/5)-th closest predictor
vector divided by the distance to the furthest. Except for
patient 209 (whose fraction was 0.42) these lower limits
were less than 0.2.
Discussion
We have developed a local minimax kernel learning
algorithm that is capable of making individualized pre-
diction in several microarray cancer gene expression
data sets. This method incorporates two learning algo-
rithms: the unique features of the k-TSP algorithm by
retaining its simple and accurate decision rules, and
adding estimated probability and confidence interval for
individualized prediction from a local minimax kernel
learning algorithm. Moreover, our predictions can be
made on an individual basis with local estimated prob-
ability and confidence level, which are currently not
available in the predictions of other learning methods.
Cancer is heterogeneous in nature, where every
patient’s tumor harbors different genetic alterations,
even though they have the same cancer type [14].
Understanding these genetic variations between indivi-
duals could have a profound impact in combating this
disease; as one of the major clinical challenges is to
identify a subset of patients who could benefit from cer-
tain type of chemotherapies, both in metastatic and
adjuvant settings [1,2].
Machine learning or statistical learning approaches
have been widely used to classifying and stratifying can-
cer patient data based on gene expression data [5-7]. In
general, current machine learning classifiers only report
global error rates over a large population [5-7]. Such
rates are useful for epidemiologists and hospital admin-
istrators trying to predict future trends, loads, and dis-
ease rates. However, in a clinical setting, a global error
rate is of little comfort to the patient and his or her
doctor. This is where our methods have a distinct
advantage. Since we are able to label our predictions as
either being confidently predicted or non-confidently
predicted, these methods have the potential to be more
powerful in the context of sequential analysis than the
current standard methods.
Physicians requiring a greater level of confidence may
decide to classify using a smaller predictability thresh-
old. Similarly, doctors seeking to be able to confidently
predict for a larger number of patients may choose to
use a slightly higher threshold. These values may be
investigated and adjusted over time so as to be of the
most appropriate usefulness given whatever analytical
context the doctor is working in at that time. Thus, by
providing the physician with not only the prediction,
but also with a level of confidence, and with error
bounds associated with that prediction, we are able to
empower the physician to make use of a larger number
of more finely-grained protocols that he or she may
Table 2 Leave-one-out comparisons of the local minimax learning with 3-nearest neighbor predictor and the kernel
predictors (sigma = 0.5 and 0.7, p = 0.35)
3-nearest neighbor predictor Kernel predictor with sigma = 0.5, e = 0 Kernel predictor with sigma = 0.7, e = 0
Data Set CP (%) Error in CP. (%) Total Error (%) CP (%) Error in CP (%) Total Error (%) CP (%) Error in CP (%) Total Error (%)
Leukemia 71 3 3 36 3 43 3
(98.6%) (4.23%) (4.17%) (50.0%) 0 (0%) (4.17%) (59.7%) 0 (0%) (4.17%)
Prostate 54 11 21 32 4 21 34 4 22
(61.4%) (20.4%) (23.9%) (36.4%) (12.5%) (23.9%) (38.6%) (11.8%) (25%)
GCM 204 15 38 154 6 39 160 6 42
(72.9%) (7.35%) (13.6%) (55.0%) (3.9%) (13.9%) (57.1%) (3.75%) (15%)
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allows the physician many more options when designing
how they want to sequentialize their various treatment
options for various types of patients given various
observations.
It must be emphasized that we only demonstrate
improved classification for the kernel classifier using
squared error loss. The analogous finite sample local
accuracy bounds are not available for other methods
(with the exception of linear regression [10]). So a very
important question is whether similar localization
results which identify confident prediction are valid for
other algorithms. To this end we formulate important
new open mathematical questions whose solutions
would characterize confident predictability for a local
version of kernel learning with hinge loss (Support Vec-
tor Machine- SVM), for single hidden layer neural net-
work local learning with squared error loss, and for
logistic regression local learning with squared error loss.
Solution to these questions will provide both the oppor-
tunity to compare various algorithms for individualized
performance as well as lead to possible fusion of several
algorithms into an algorithm with superior global per-
formance. For instance a classifier which applies both a
neural net and a local kernel algorithm to a queried
patient, making a decision based on the more confi-
dently predictable output, could have a global error rate
significantly lower than either classifier.
Open Problems
I nt h i ss t u d yw eh a v eo n l ya p p l i e df i n i t es a m p l el o c a l
minimax bounds for Tikhonov kernel learning (i.e. using
squared error loss) and obtained improved accuracy. An
important open problem is to obtain local accuracy
bounds for the support vector machine (which uses
hinge loss and fits linear combinations of the kernel
with prescribed bandwidth s while penalizing by adding
a constant times square of the reproducing kernel norm
of the linear combination) and examine the improve-
ment via confident predictability for that machine. One
approach to this problem is to optimally map the SVM
discriminant function g(x) to the interval 0[1] by s(g(x))
yielding a probability of cancer estimate and then obtain
results on the mean squared error of that estimate at xo.
Patient 12 Patient 209
Patient 244 Patient 253
sigma = 0.5
0.963 [90%CI 0.832 - 1.0]
sigma = 0.5
0 [90%CI 0 - 0.225]
sigma = 0.5
0.580 [90%CI 0.463 - 0.698]
sigma = 0.5
0.834 [90%CI 0.578 - 1.0]
Figure 2 Estimated predicted probability and 90% confidence intervals (90% CI) for the four patients in GCM data set.
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error loss for logistic regression or more generally for a
probability of cancer expression which is a ridge func-
tion. Here consider the same affine estimators of the
form Fw w w Y jj
j
N
() =+
∗
= ∑
1
,b u ta s s u m ef(x) is a sigmoidal
function exp{ao + a·x}/(1 + exp{ao + a·x}) with a pre-
scribed bound on the length of a, and then get a bound
on the mean squared error at xo. We might also do this
when f is of the form h(ao + a·x) ,where a is a unit vec-
tor, for some class of univariate h’s. Finally a local accu-
racy bound is desired for the single hidden layer neural
network and its potential for extending confident pre-
dictability to neural network classifiers. Here consider
again affine estimators but assume f(x) is a convex com-
bination of n sigmoidal functions, where the i’th is of
the form exp{ai,o + ai·x}/(1 + exp{ ai,o + ai·x }) with a
prescribed bound on the lengths of the ai,a n dt h e ng e t
a bound on the mean squared error at xo.
Conclusions
In summary, we have devised a new learning method
that implements: (i) feature selection using the k-TSP
algorithm and (ii) classifier construction by local mini-
max kernel learning. We tested our method on three
publicly available gene expression datasets and achieved
significantly lower error rate for a substantial identifiable
subset of patients. Our final classifiers are simple to
interpret and they can make prediction on an individual
basis with an individualized confidence level. We believe
that our method can be a useful tool to translate the
gene expression signatures into clinical practice for per-
sonalized medicine.
Appendix
We will outline the derivation of the bounds and algo-
rithms for the case i = N (all N training vectors are
used). The results are clearly also valid for i = 1,2,..., N.
We suppress the subscript N a n dj u s tu s et h en o t a t i o n
V, K,s*, £ etc.
Consider the pre-Hilbert space of models f (x;a)=
Σax·K(x’, x) where the sums are initially over finitely
many x ;where K (u,v), is a piecewise continuous,
bounded symmetric, non-negative kernel function on V
× V , positive at diagonal points (uu ); and where the
matrix K (zi, zj) is positive semi-definite for any finite
{zi} ⊆ V (positive definite for distinct zi ). Define an
inner product [f (x;a), f (x;b)] = ΣΣax’bx’’K(x’,x’’). Now
extend this to form a real Hilbert space by completion.
For any g in the constructed Hilbert space, g can be
identified with the point wise limit of a sequence of
models in the pre-Hilbert space which converges to g in
the constructed Hilbert space. It can easily be shown
that [g,K(u,-)] = g (u), where g (u) is the value of the
associated point wise limit at u . Hence the space is
called a reproducing kernel Hilbert space (RKHS).
A s s u m e ,t h r o u g h o u tt h a t| || |e q u a l sR K H Sn o r ma n d
that there are N predictors {xi}⊆ V .
Let M = {g: the RKHS norm of g is less than or equal
to M}. By translation we may assume that the query
vector x0 = 0. The following two theorems are proven in
[10], for the more general case of f (x) being within ε(x)
in V (where ε (0) = 0) of some member of the family M.
Theorem I (Minimax Query-based Vector Machine)
Let f (x) be any function (not just a “probability of class 1
given x“ function) in M, Yj =f(xj) +N j , j = 1,2,..., N and
noise covariance matrix N the bounded (in the semi-defi-
nite order - i.e. s - N is positive semi-definite) by a posi-
tive definite s (in this paper s =0 . 2 5I). Consider the
matrix K*=( ( K (xi,xj))):i , j = 0,1,2,..., N .(V is centered at
the query point x0 which we are taking as 0 but the
results obtained are the same for any query point x0 by
changing x0 to the origin and subtracting x0 from each
predictor xj). Set w0 =- 1(w has now N + 1 components),
s* equal the N +1b yN + 1 matrix formed by adding a
0-th row and 0-th column of zeros to the noise covar-
iance matrix upper bound s,a n dt h eN +1d i m e n s i o n a l
vector u = (1,0,0,...,0)
t. Let £ = 1
2 1
uMu
t s s
** + ()
−
K
.
Then the mean squared error of F(w), where w*=0
(Note F (w) does not involve w0), is bounded by £ if
w Mu
uMu
t
=− + ()
+ ()
−
−
 
 
**
**
2 1
2 1
K
K
a n dt h i si st h eb e s tp o s s i b l e
bound on mean squared error if we allow any noise cov-
ariance N bounded in semi definite order by s.
Proof: see theorem VI in [10].
Theorem II (Vector Machine with Context)
Assume hypotheses and notation of Theorem I except f
(x) takes values in 0[1] and is in PKa (V ). Then the esti-
mator F (w), which equals F (w) of Theorem I except
that w*=- a (w0 + w1 + ... + wN), has mean squared
error bounded by £ of Theorem I
when
w
Mu
uMu
t
=−
+ ()
+ ()
−
−
 
 
**
**
2 1
2 1
K
K
where we have
MM K y x g x V
xV yV PK V ==+ − () ()() ( ) ≥ () − ()
∈ ∈
()  

2 2
1
2
1
2 1 max min , sup . .
For such M , we call F (w) the contextual Tikhonov
estimator. In fact, for any M greater than or equal the
r i g h th a n ds i d eo ft h ea b o v ei n e q u a l i t y ,t h es a m er e s u l t
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Page 8 of 9holds. A good choice for a is 0.5 (which is used in our
experiments) since it minimizes MV as a function of a.
Proof: see theorem VII of [10].
Confidence analysis
As F (w) is near normal in many situations according to
the Lindeberg-Feller theorem, we can give approximate
confidence intervals for f (0). Let F (w)b en o r m a lw i t h
mean μ, standard deviation s and root mean squard error
r. For b < 0.5 denote by zb the (1 - b)’th normal quantile.
Then Pr {F (w)-μ ≤ szb}=1-b =P r{ F(w)-f (0) ≤ szb +
μ - f (0)} = () − () ≤− () +
⎧
⎨
⎪
⎩ ⎪
⎫
⎬
⎪
⎭ ⎪
Pr Fw f x z x 0
22
1
2   ,
with x = μ - f (0). (note that r
2 - x
2 = s
2).
Now maximize the right hand side inside the
brackets as a function of x and we obtain
Pr . Fw f z () − () ≤+ ()
⎧
⎨
⎪
⎩ ⎪
⎫
⎬
⎪
⎭ ⎪
≥− 01 1
2
1
2   .
The inequality Pr Fw f z () − () ≥− + ()
⎧
⎨
⎪
⎩ ⎪
⎫
⎬
⎪
⎭ ⎪
≥− 01 1
2
1
2   is
d e r i v e di na ni d e n t i c a lf a s h i o n .I fr is just an upper
bound on the actual root mean squared error, the
inequalities remain valid. Hence for such r we have
level (1 - b) confidence intervals
Fw z Fw z () −+ () +∞
⎛
⎝
⎜
⎞
⎠
⎟ −∞ () ++ ()
⎛
⎝
⎜
⎞
⎠
⎟   11
2
1
2 2
1
2 ,,, and (using
the inequality) Fw z () ±+ ()   1 2
2
1
2
/ . In particular a 95%
confidence interval is F ±2 . 2 2 r ,i n s t e a do ft h eu s u a lF ±
1.96s = F ±1 . 9 6 r for unbiased F .H e r ew eu s et h e9 0 %
confidence interval (F (w) - 1.621r,+∞)o r( - ∞,F (w)+
1.62r).
Acknowledgements
The authors would like to acknowledge the constructive comments from
the reviewers and associate editor to improve the presentation of this
manuscript. Part of this work was supported by NIH/NCRR Colorado CTSI
Grant Number UL1 RR025780 CO-Pilot Grant Award (ACT). Its contents are
the authors’ sole responsibility and do not necessarily represent official NIH
views.
Author details
1Department of Mathematical Sciences, University of Massachusetts, Lowell,
MA, USA.
2Division of Medical Oncology, Department of Medicine, University
of Colorado Denver School of Medicine, Anschutz Medical Campus, Aurora,
CO, USA.
Authors’ contributions
LKJ and ACT proposed the research, designed the study and supervised the
project. LKJ, AK and KR derived the mathematical theorems and proofs. LKJ,
ACT, FZ and DB implemented the algorithms, performed the analysis and
interpreted the results. LKJ, ACT and FZ wrote the manuscript. All authors
have read and approved the manuscript.
Received: 17 May 2010 Accepted: 24 January 2011
Published: 24 January 2011
References
1. Chin L, Gray JW: Translating insights from the cancer genome into
clinical practice. Nature 2008, 452:553-563.
2. Van’t Veer LJ, Bernards R: Enabling personalized cancer medicine through
analysis of gene-expression patterns. Nature 2008, 452:564-570.
3. Van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, Peterse HL,
van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Krekhoven RM,
Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling
predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
4. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D,
Lancaster JM, Berchuck A, Olson JAJr, Marks JR, Dressman HK, West M,
Nevins JR: Oncogenic pathway signatures in human cancers as a guide
to targeted therapies. Nature 2006, 439:353-357.
5. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG,
Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N: A
multigene assay to predict recurrence of tamoxifen-treated, node-
negative breast cancer. N Engl J Med 2004, 351:2817-2826.
6. Larrañaga P, Calvo B, Santana R, Bielza C, Galdiano J, Inza I, Lozano JA,
Armañanzas R, Santafé G, Pérez A, Robles V: Machine learning in
bioinformatics. Brief Bioinform 2006, 7:86-112.
7. Tan AC, Gilbert D: Ensemble machine learning on gene expression data
for cancer classification. Appl Bioinformatics 2003, 2:S75-S83.
8. MAQC Consortium: The MicroArray Quality Control (MAQC)-II study of
common practices for the development and validation of microarray-
based predictive models. Nature Biotechnology 2010, 28:827-838.
9. Tan AC, Naiman DQ, Xu L, Winslow RL, Geman D: Simple decision rules for
classifying human cancers from gene expression profiles. Bioinformatics
2005, 21:3896-3904.
10. Jones LK: Local minimax learning of functions with best finite sample
estimation error bounds: applications to ridge and lasso regression,
boosting, tree learning, kernel machines, and inverse problems. IEEE
Transactions on Information Theory 2009, 55:5700-5727.
11. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP,
Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES:
Molecular classification of cancer: class discovery and class prediction by
gene expression monitoring. Science 1999, 286:531-537.
12. Stuart RO, Wachsman W, Berry CC, Wang-Rodriguez J, Wasserman L,
Klacansky I, Masys D, Arden K, Goodison S, McClelland M, Wang Y,
Sawyers A, Kalcheva I, Tarin D, Mercola D: In silico dissection of cell-type-
associated patterns of gene expression in prostate cancer. Proc Natl Acad
Sci USA 2004, 101:615-620.
13. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M,
Ladd C, Reich M, Latulippe E, Mesirov JP, Poggio T, Gerald W, Loda M,
Lander ES, Golub TR: Multiclass cancer diagnosis using tumor gene
expression signatures. Proc Natl Acad Sci USA 2001, 98:15149-15154.
14. Weinberg RA: The Biology of Cancer. Garland Science 2006.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1755-8794/4/10/prepub
doi:10.1186/1755-8794-4-10
Cite this article as: Jones et al.: Confident Predictability: Identifying
reliable gene expression patterns for individualized tumor classification
using a local minimax kernel algorithm. BMC Medical Genomics 2011 4:10.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Jones et al. BMC Medical Genomics 2011, 4:10
http://www.biomedcentral.com/1755-8794/4/10
Page 9 of 9